Robustness Optimization of an Existing Tablet Coating Process Applying Retrospective Knowledge (rQbD) and Validation

The objective of these studies is to verify and validate the improvement in the inter-tablet coating uniformity for an industrially commercialized coated tablet, without involving changes in the approved registration dossier. Using the CPP (critical process parameters) determined from previous retro...

Full description

Bibliographic Details
Authors: Galí Serra, Albert; Ascaso Anglés, Magda; Nardi Ricart, Anna; Suñé Pou, Marc; Pérez Lozano, Pilar; Suñé i Negre, Josep M. (Josep Maria); García Montoya, Encarna
Format: Article
Status:Published version
Publication date:2020
Country:España
Institution:Universidad de Barcelona
Repository:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/173526
Online Access:https://hdl.handle.net/2445/173526
Access Level:Open access
Keyword:Síntesi de fàrmacs
Drug synthesis
_version_ 1878742837878587393
author Galí Serra, Albert
author2 Ascaso Anglés, Magda
Nardi Ricart, Anna
Suñé Pou, Marc
Pérez Lozano, Pilar
Suñé i Negre, Josep M. (Josep Maria)
García Montoya, Encarna
author2_role author
author
author
author
author
author
author_browse Ascaso Anglés, Magda
Galí Serra, Albert
García Montoya, Encarna
Nardi Ricart, Anna
Pérez Lozano, Pilar
Suñé Pou, Marc
Suñé i Negre, Josep M. (Josep Maria)
author_facet Galí Serra, Albert
Ascaso Anglés, Magda
Nardi Ricart, Anna
Suñé Pou, Marc
Pérez Lozano, Pilar
Suñé i Negre, Josep M. (Josep Maria)
García Montoya, Encarna
author_role author
collection Dipòsit Digital de la UB
description The objective of these studies is to verify and validate the improvement in the inter-tablet coating uniformity for an industrially commercialized coated tablet, without involving changes in the approved registration dossier. Using the CPP (critical process parameters) determined from previous retrospective statistical analysis, the recommended working ranges are identified. Retrospective analysis showed that the design of experiments (DoE) provided an improved process variable configuration. Therefore, it is decided to study two critical parameters: Product temperature and drum speed, with an additional 22 experimental design. The quality results of the samples analyzed show that the aesthetic defects of the batches made with the new working ranges have been reduced. These results have also been corroborated with the 42 industrial batches manufactured with the new ranges. With the optimized parameters, tablets have been coated and the suitability of the model determined. The results demonstrated the overall reliability and effectiveness of the proposed Quality by Design approach and provides a useful tool to help optimize the industrial coating process. This study confirms that it is possible to optimize and validate the manufacturing process of an existing commercial product by means of a DoE with retrospective data. Therefore, no variation in the dossier is required.
eu_rights_str_mv openAccess
format article
id ES_fd2f9eabf5ca09e404d0eb341e59c8cd
institution Universidad de Barcelona
instname_str Universidad de Barcelona
network_acronym_str ES
network_name_str España
oai_identifier_str oai:diposit.ub.edu:2445/173526
publishDate 2020
publishDateSort 2020
publisher MDPI
publisherStr MDPI
reponame_str Dipòsit Digital de la UB
spelling Robustness Optimization of an Existing Tablet Coating Process Applying Retrospective Knowledge (rQbD) and Validation Galí Serra, Albert Ascaso Anglés, Magda Nardi Ricart, Anna Suñé Pou, Marc Pérez Lozano, Pilar Suñé i Negre, Josep M. (Josep Maria) García Montoya, Encarna Síntesi de fàrmacs Drug synthesis The objective of these studies is to verify and validate the improvement in the inter-tablet coating uniformity for an industrially commercialized coated tablet, without involving changes in the approved registration dossier. Using the CPP (critical process parameters) determined from previous retrospective statistical analysis, the recommended working ranges are identified. Retrospective analysis showed that the design of experiments (DoE) provided an improved process variable configuration. Therefore, it is decided to study two critical parameters: Product temperature and drum speed, with an additional 22 experimental design. The quality results of the samples analyzed show that the aesthetic defects of the batches made with the new working ranges have been reduced. These results have also been corroborated with the 42 industrial batches manufactured with the new ranges. With the optimized parameters, tablets have been coated and the suitability of the model determined. The results demonstrated the overall reliability and effectiveness of the proposed Quality by Design approach and provides a useful tool to help optimize the industrial coating process. This study confirms that it is possible to optimize and validate the manufacturing process of an existing commercial product by means of a DoE with retrospective data. Therefore, no variation in the dossier is required. MDPI https://hdl.handle.net/2445/173526
spellingShingle Robustness Optimization of an Existing Tablet Coating Process Applying Retrospective Knowledge (rQbD) and Validation
Galí Serra, Albert
Síntesi de fàrmacs
Drug synthesis
status_str publishedVersion
title Robustness Optimization of an Existing Tablet Coating Process Applying Retrospective Knowledge (rQbD) and Validation
title_full Robustness Optimization of an Existing Tablet Coating Process Applying Retrospective Knowledge (rQbD) and Validation
title_fullStr Robustness Optimization of an Existing Tablet Coating Process Applying Retrospective Knowledge (rQbD) and Validation
title_full_unstemmed Robustness Optimization of an Existing Tablet Coating Process Applying Retrospective Knowledge (rQbD) and Validation
title_short Robustness Optimization of an Existing Tablet Coating Process Applying Retrospective Knowledge (rQbD) and Validation
title_sort Robustness Optimization of an Existing Tablet Coating Process Applying Retrospective Knowledge (rQbD) and Validation
topic Síntesi de fàrmacs
Drug synthesis
topic_facet Síntesi de fàrmacs
Drug synthesis
url https://hdl.handle.net/2445/173526